Tandem Diabetes Care Reports Results for Quarter Ended June 30, 2026

What Happened
Tandem Diabetes Care, Inc. announced its financial results for the quarter ended June 30, 2026 via a press release dated August 6, 2026. The company filed a Form 8-K (Accession No. 0001438133-26-000124) reporting these results under Item 2.02 (Results of Operations and Financial Condition) and furnished the press release as Exhibit 99.1. The filing was signed by Shannon M. Hansen, Executive Vice President, Chief Legal, Privacy & Compliance Officer and Secretary, on August 6, 2026.

Key Details

• Filing date: August 6, 2026 (Form 8-K; Accession No. 0001438133-26-000124).
• Period covered: quarter ended June 30, 2026.
• Press release: furnished as Exhibit 99.1 and incorporated by reference in the 8-K.
• Authorized signatory: Shannon M. Hansen (title listed and signed on Aug 6, 2026).

Why It Matters
This 8-K signals that Tandem has publicly released its latest quarterly financial results; investors should review the furnished press release (Exhibit 99.1) for the specific revenue, earnings, cash flow, and any management commentary or guidance. The filing documents timely disclosure to the market and points to where the detailed quarterly figures and related company commentary can be found.